Clinical Trials on Basal Tryptasemia in Norway

Total 43 results

Oslo University Hospital

Enrolling by invitation

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Basal Cell Carcinoma | Gorlin Syndrome

Norway
Norwegian University of Science and Technology

Completed

Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear

Carcinoma, Basal Cell | Porokeratosis, Disseminated Superficial Actinic

Norway
Norwegian University of Science and Technology
Oslo University Hospital; Helse Stavanger HF; Haukeland University Hospital; Førde... and other collaborators

Completed

New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

Carcinoma, Basal Cell | Skin Neoplasms

Norway
Haukeland University Hospital

Completed

NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease (NR-SAFE)

Parkinson Disease

Norway
Oslo University Hospital
South-Eastern Norway Regional Health Authority

Active, not recruiting

Effects of Deep Brain Stimulation in Parkinson's Disease

Parkinson's Disease

Norway
Haukeland University Hospital

Recruiting

N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease

Parkinson Disease

Norway
University Hospital, Akershus
Solvay Pharmaceuticals

Completed

Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit

Parkinson Disease

Norway
Oslo Metropolitan University
Karolinska Institutet; Aalborg University Hospital; Fysiofondet; Unicare Fram; Norwegian... and other collaborators

Recruiting

Exercise Adherence and Optimal Nutrition Post Rehabilitation Among People With Parkinson's Disease (mHEXANUT)

Parkinson Disease

Norway
Haukeland University Hospital

Completed

NAD-supplementation in Drug naïve Parkinson's Disease (NAD-PARK)

Parkinson Disease | Neurodegenerative Diseases

Norway
Helse Stavanger HF

Recruiting

Online Cognitive Behavioral Therapy for Depressive Symptoms in Parkinson's Disease (ePark)

Parkinson Disease | Anxiety | Depressive Symptoms

Norway
Meddoc

Completed

Validation of Bulbicam for Parkinson- and Ataxia-patients

Parkinson Disease | Ataxia

Norway
Helse Fonna
Helse-Bergen HF; Klinbeforsk

Recruiting

Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial (ANeED)

Dementia With Lewy Bodies

Norway
University of Bergen
Ullevaal University Hospital; Helse Stavanger HF; St. Olavs Hospital; Helse Fonna; University Hospital, Akershus and other collaborators

Recruiting

ANeED Joint Effort 21: eHealth and a PPI Program in Dementia With Lewybodies (DLB) (JointEffort21)

Dementia, Lewy Body

Norway
Galderma R&D

Completed

PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer

Warts | Actinic Keratosis | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowens Disease

Denmark, Germany, Norway, Sweden, United Kingdom
Sorlandet Hospital HF

Recruiting

Nasal Breathing and Physical Capacity

Copd | Nasal Obstruction

Norway
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

Rhinitis | Chronic Disease | Nasal Polyposis

Norway
Haukeland University Hospital

Recruiting

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease (NOPARK)

Parkinson Disease

Norway
Helse Stavanger HF
University Hospital, Akershus

Unknown

Challenge Test for Acetylsalicylic Acid Hypersensitivity

Asthma, Aspirin-Induced | ASA Intolerant Asthma | Asthma Aspirin-sensitive | Asthma, Nasal Polyps, and Aspirin Intolerance

Norway
University of Bergen
NKS Olaviken Alderspsykiatriske sykehus

Completed

Tailored Music Therapy for Dementia

Dementia, Vascular | Alzheimer Dementia | Dementia, Lewy Body | Dementia Parkinson's Disease

Norway
Lovisenberg Diakonale Hospital

Unknown

The Role of the Nose in Snoring and Sleep Apnea

Nasal Obstruction | Apnea, Obstructive Sleep

Norway
Norwegian University of Science and Technology
Sorlandet Hospital HF

Completed

Nasal Obstruction in Sleep Apnea Patients Compared to the General Population

Nasal Obstruction | Obstructive Sleep Apnoea Syndrome

Norway
Haukeland University Hospital
Nordlandssykehuset HF; Helse Møre og Romsdal HF; Helse Fonna HF; Oslo universitetssykehus... and other collaborators

Not yet recruiting

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism (NADAPT)

Multiple System Atrophy | Progressive Supranuclear Palsy | Corticobasal Syndrome

Norway
Helse Stavanger HF
King's College London; Lund University

Completed

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB) (MEMPDD)

Dementia With Lewy Bodies | Dementia Associated With Parkinson's Disease

United Kingdom, Norway, Sweden
Hoffmann-La Roche

Completed

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Basal Cell Carcinoma

Italy, Czechia, Hungary, Belgium, Canada, Ireland, Mexico, Portugal, Slovenia, Spain, Turkey, Brazil, Bosnia and Herzegovina, Romania, United Kingdom, Germany, Israel, France, Greece, Russian Federation, Lithuania, Netherlands, Norway, Colomb... and more
CHDI Foundation, Inc.

Completed

Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers (LONGPDE10)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
CHDI Foundation, Inc.

Completed

[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET. (PEARL-HD)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
Institut National de la Santé Et de la Recherche...

Unknown

Clinical, Molecular and by Neuroimaging of LRRK2 Mutations (LRRK2)

Parkinson's Disease

France
Assistance Publique - Hôpitaux de Paris
France Parkinson Association

Unknown

Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET (INFLAPARK)

Healthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 Mutation

France
Commissariat A L'energie Atomique

Terminated

PET Study of the Nicotinic Receptors in Human

Epilepsy | Healthy | Parkinson Disease | Alzheimer Disease

France
Anglia Ruskin University
University of Melbourne; Alzheimer's Society; Norwegian Academy of Music; Cambridgeshire... and other collaborators

Completed

Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia (HOMESIDE)

Depression | Quality of Life | Dementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia Alzheimers | Behavioural and Psychiatric Symptoms of Dementia

United Kingdom, Australia, Germany, Norway, Poland
Biogen
Ionis Pharmaceuticals, Inc.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease (REASON)

Parkinson's Disease

United States, Spain, Israel, Canada, Norway, United Kingdom
Incyte Corporation

Active, not recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Cervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditions

Finland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
Ken Marek, MD
Institute for Neurodegenerative Disorders

Completed

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression (PPMI)

Parkinson Disease

United States, Spain, Israel, Norway, Germany, Italy, United Kingdom, France, Austria, Australia, Greece
Travere Therapeutics, Inc.

Terminated

Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants (PKAN)

Pantothenate Kinase-Associated Neurodegeneration

United States, Canada, Czechia, France, Germany, Italy, Norway, Poland, Spain
Genzyme, a Sanofi Company

Terminated

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation (MOVES-PD)

Parkinson's Disease

United States, Austria, Canada, France, Germany, Greece, Israel, Italy, Japan, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Advanced Stage Parkinson's Disease

France, Italy, Poland, United Kingdom, Spain, Germany, South Africa, New Zealand, Czech Republic, Hungary, Australia, Austria, Israel, Sweden, Norway, Croatia, Finland
Optinose US Inc.

Completed

12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

Nasal Polyps

United States
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Early Stage Parkinson's Disease

Poland, United Kingdom, Germany, Spain, Switzerland, Belgium, South Africa, New Zealand, Czech Republic, Austria, Hungary, Australia, Italy, Israel, Sweden, Norway, Croatia, Netherlands, Finland, France
Boehringer Ingelheim

Completed

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

Depression | Parkinson Disease

Austria, Finland, France, Germany, Italy, Netherlands, Norway, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine
CENTOGENE GmbH Rostock

Recruiting

Rostock International Parkinson's Disease Study (ROPAD) (ROPAD)

Parkinson´s Disease

Spain, Israel, United Kingdom, United States, Germany, Albania, Belgium, Brazil, Canada, France, Greece, Italy, Portugal, Turkey, Norway
European Huntington's Disease Network

Completed

REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN) (REGISTRY)

Huntington Disease | Huntington's Disease

Finland, United Kingdom, Austria, Belgium, Czechia, Denmark, France, Germany, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland
Chelsea Therapeutics

Completed

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease (306A/306B)

Parkinson's Disease | Orthostatic Hypotension

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden

Clinical Trials on Basal Tryptasemia in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations